Search

  • HOME
  • Search
Correspondence
Correspondence to letter to the editor 1 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
Clin Mol Hepatol. 2025;31(1):e96-e97.   Published online November 11, 2024
View: 831   Download: 13
Correspondence to editorial on “KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression”
Sang Bae Lee, KyeongJin Kim
Clin Mol Hepatol. 2025;31(1):e78-e80.   Published online September 10, 2024
View: 1116   Download: 73
Reply to Correspondence
Reply to correspondence on “Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis”
Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang
Clin Mol Hepatol. 2024;30(4):1042-1043.   Published online August 27, 2024
View: 1496   Download: 32  Web of Science: 1  Crossref: 3
Correspondence
Correspondence to editorial on “Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients”
Xiaoqian Xu, Hong You, Jidong Jia, Yuanyuan Kong
Clin Mol Hepatol. 2024;30(4):994-996.   Published online July 23, 2024
View: 1545   Download: 37  Web of Science: 1  Crossref: 1
Original Article
1992
KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression
Young Hoon Jung, Yun Ji Lee, Tam Dao, Kyung Hee Jung, Junjie Yu, Ah-Reum Oh, Yelin Jeong, HyunJoon Gi, Young Un Kim, Dongryeol Ryu, Michele Carrer, Utpal B. Pajvani, Sang Bae Lee, Soon-Sun Hong, KyeongJin Kim
Clin Mol Hepatol. 2024;30(4):895-913.   Published online August 5, 2024
View: 3140   Download: 320  Web of Science: 2  Crossref: 2
Review
Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication
Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu
Clin Mol Hepatol. 2024;30(3):326-344.   Published online April 26, 2024
View: 4180   Download: 171  Web of Science: 10  Crossref: 7
Editorial
The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective
Carlos Jose Pirola, Silvia Sookoian
Clin Mol Hepatol. 2024;30(2):174-176.   Published online February 5, 2024
View: 3306   Download: 85  Web of Science: 1  Crossref: 2
The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B
Xianhua Mao, Lung Yi Mak, Wai-Kay Seto
Clin Mol Hepatol. 2023;29(3):690-692.   Published online May 30, 2023
View: 3291   Download: 113  Web of Science: 2  Crossref: 2
Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
Philipp Kasper, Münevver Demir, Hans-Michael Steffen
Clin Mol Hepatol. 2023;29(2):390-393.   Published online March 20, 2023
View: 4057   Download: 69  Web of Science: 2  Crossref: 2
Review
1457
Detect or not to detect very early stage hepatocellular carcinoma? The western perspective
Ju Dong Yang
Clin Mol Hepatol. 2019;25(4):335-343.   Published online March 29, 2019
View: 12497   Download: 260  Web of Science: 48  Crossref: 43
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
Chung-Feng Huang, Ming-Lung Yu
Clin Mol Hepatol. 2019;25(2):168-171.   Published online February 11, 2019
View: 6974   Download: 190  Web of Science: 5  Crossref: 5
4
A Case of Complete Remission in Ruptured Hepatocellular Carcinoma after One - time Transcatheter Arterial Chemoembolization
Doo Yul Ryu,Duc Ky Lee,Jong Hyung Kim,Hyun Min Shin,Dong In Hwang,Dong Joo Lee,Sang Kook Han,Seok En Kim,Suk Joon Park
Clin Mol Hepatol. 1999;5(4):343-347.   Published online January 1, 2000
View: 2560   Download: 14
3
Serum Concentration of Intercellular Adhesion Molecule-1 (ICAM-1) in Patients with Hepatocellular Carcinoma (HCC) with Low AFP
Hyun Ju Park, Joung Il Lee, Seok Ho Dong, Hyo Jong Kim, Byoung Ho Kim, Young Woon Chang and Rin Chang
Clin Mol Hepatol. 1998;4(4):346-357.   Published online January 1, 2000
View: 2656   Download: 14
Editorial
Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma
Valerie Chew
Received March 25, 2025  Accepted March 28, 2025  
View: 499   Download: 41
Original Article
MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation
Tiantian Wang, Dean Rao, Chenan Fu, Zhoubin Sun, Yiming Luo, Junli Lu, Jie Jin, Han Li, Feimu Fan, Huifang Liang, Wenjie Huang, Limin Xia
Received December 24, 2024  Accepted April 8, 2025  
View: 1211   Download: 199
Editorial
Uncovering the MET-TRIB3-FOXO1 axis: A Novel Target in MET-driven Hepatocellular Carcinoma
Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
Received May 9, 2025  Accepted May 13, 2025  
View: 411   Download: 42
Reply to Correspondence
Reply to correspondence on “MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation”
Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
Received May 26, 2025  Accepted May 30, 2025  
View: 217   Download: 8
Review
Prospects of Mendelian Randomization in Hepatology: A Comprehensive Literature Review with Practice Guidance Mendelian randomization and hepatology
Lanlan Chen, Qi Rao, Menghan Gao, Guoyue Lv, Frank Tacke
Received May 16, 2025  Accepted June 3, 2025  
View: 526   Download: 49
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1469
TOTAL : 2803356
Close layer